Objoon Trachoo

Dr. Objoon Trachoo is a Clinical Associate Professor and Chair of Medical Genetics at the College of Health Sciences, VinUniversity, Hanoi, Vietnam. He also contributes as an International Scholar to the Center for Global Health at the University of Pennsylvania. His work bridges clinical genetics, genomics, and global health, focusing on improving genetic services in Southeast Asia.

Dr. Trachoo specializes in Fetal Medicine, Medical Genetics, Neurogenetics, and Rare Diseases. His research emphasizes the genomic diagnosis of conditions such as early-onset epileptic encephalopathy, cardiomyopathy, aortopathy, and undiagnosed rare disorders. He integrates clinical evaluation with genomic data interpretation to enable precision medicine, genetic counseling, and preventive care for families.

His recent publications (2019–2024) highlight work in genetic epilepsy, inherited heart disease, rare neurodegenerative conditions, and preimplantation genetic testing. These studies reflect a strong trend toward translational genomics, particularly in underrepresented populations in Thailand and Vietnam, with applications in reproductive health, pediatric neurology, and stem cell therapy.

Scientific Awards and Recognitions:

• FIBMS (Fellow of the Institute of Biomedical Science)

Dr. Trachoo is actively involved in mentoring and global health programs. He leads the development of medical genetics infrastructure at VinUniversity and its teaching hospitals, and collaborates internationally on research and training. His projects include implementing genomic screening for rare diseases, training local clinicians, and building sustainable genetics services in resource-limited settings. He has led initiatives in Thailand and Vietnam with support from global health networks.

He is associated with research teams focused on genomic diagnostics, fetal medicine, and rare disease discovery, often collaborating with pediatric neurologists, cardiologists, and reproductive specialists. His labs and clinical teams work on integrating next-generation sequencing into routine care, family cascade screening, and international data sharing for undiagnosed diseases.